Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- Structure
4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- structure
CAS No.
2095668-10-1
Chemical Name:
4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-
Synonyms
VIT-2763;Vamifeport;Vamifeport, 10 mM in DMSO;4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-;2-(2-((2-(1H-Benzo[d]imidazol-2-yl)ethyl)amino)ethyl)-N-((3-fluoropyridin-2-yl)methyl)oxazole-4-carboxamide;2-[2-[[2-(1H-Benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-4-oxazolecarboxamide (ACI)
CBNumber:
CB38134401
Molecular Formula:
C21H21FN6O2
Molecular Weight:
408.43
MDL Number:
MOL File:
2095668-10-1.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-08-30 11:39:11
Request For Quotation

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- Properties

Boiling point 727.8±60.0 °C(Predicted)
Density 1.339±0.06 g/cm3(Predicted)
pka 11.87±0.46(Predicted)
form Solid
color Off-white to light yellow
FDA UNII FUF66UD0KR

SAFETY

Risk and Safety Statements

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319
Precautionary statements  P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biosynth VID66810 VIT-2763 2095668-10-1 10mg $776.2 2026-06-05 Buy
Biosynth VID66810 VIT-2763 2095668-10-1 25mg $1455.5 2026-06-05 Buy
Biosynth VID66810 VIT-2763 2095668-10-1 50mg $2025 2026-06-05 Buy
ChemScene CS-0044182 VIT-2763 99.93% 2095668-10-1 5mg $213 2026-06-04 Buy
ChemScene CS-0044182 VIT-2763 99.93% 2095668-10-1 10mg $320 2026-06-04 Buy
Product number Packaging Price Buy
VID66810 10mg $776.2 Buy
VID66810 25mg $1455.5 Buy
VID66810 50mg $2025 Buy
CS-0044182 5mg $213 Buy
CS-0044182 10mg $320 Buy

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- Chemical Properties, Uses, Production

Uses

VIT-2763, an oral ferroportin inhibitor, inhibits hepcidin binding to ferroportin and blocks iron efflux. VIT-2763 has the potential in the treatment of β-thalassemia[1].

in vivo

VIT-2763 (30, 100 mg/kg, orally twice daily for 36 days) decreases serum iron and prevented liver iron loading in Hbbth3/+ mice[1].
VIT-2763 did not change the total liver iron[1].
VIT-2763 (30, 100 mg/kg, orally twice daily for 36 days) significantly corrects anemia and improved RBC parameters in Hbbth3/+ mice. VIT-2763 decreases the percentage of ROS-positive RBCs in Hbbth3/+ mice from 67% to 30%[1].
VIT-2763 decreases apoptosis and extends the life span of RBCs in Hbbth3/+ mice[1].

Animal Model:Hbbth3/+ mice[1].
Dosage:30, 100 mg/kg.
Administration:Orally twice daily for 36 days.
Result:Significantly decreased serum iron levels by 77% (30 mg/kg) and 84% (100 mg/kg),
Significantly increased Hb levels (as of day 8 of treatment), RBC counts, mean corpuscular Hb concentration (MCHC), and significantly lowered reticulocyte counts, mean corpuscular Hb (MCH), mean corpuscular volume (MCV), and RBC distribution width (RDW) in Hbbth3/+ mice, as compared with the Hbbth3/+ vehicle group.

References

[1] Vania Manolova, et al. Oral Ferroportin Inhibitor Ameliorates Ineffective Erythropoiesis in a Model of β-Thalassemia. J Clin Invest. 2019 Dec 9;130(1):491-506. DOI:10.1172/JCI129382

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- Preparation Products And Raw materials

Raw materials

Preparation Products

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- Suppliers

Global Suppliers ( 28)
Supplier Tel Email Country ProdList Advantage
ChemCell Biomedicine Co.,Ltd. 020-13556033878 2965585218 13556033878 chemcell@hotmail.com China 369 52
Shanghai Beckham Medical Technology Co., Ltd 13816613772 huahero21@sina.com China 2994 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9799 58
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
Shanghai Hongye Biotechnology Co. Ltd 400-9205774 400-920-5774 sales@glpbio.cn China 6705 58
TargetMol Chemicals Inc. +1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
BOC Sciences +1-631-485-4226 inquiry@bocsci.com United States 19935 58
Shandong Jirun Biomedical Technology Co., Ltd. 0539-0539-8613587 17661611089 2639273505@qq.com China 237 58
Suzhou youruike Chemical Pharmaceutical Technology Co., Ltd 15317229551 15151849396@163.com China 959 58
Shanghai Xiushi Biomedical Co., LTD 15002184385 15021598081 15002184385 product001@xiushipharm.com China 4710 58
Supplier Advantage
ChemCell Biomedicine Co.,Ltd. 52
Shanghai Beckham Medical Technology Co., Ltd 55
Shanghai EFE Biological Technology Co., Ltd. 58
Shanghai YuanYe Biotechnology Co., Ltd. 60
Shanghai Hongye Biotechnology Co. Ltd 58
TargetMol Chemicals Inc. 58
BOC Sciences 58
Shandong Jirun Biomedical Technology Co., Ltd. 58
Suzhou youruike Chemical Pharmaceutical Technology Co., Ltd 58
Shanghai Xiushi Biomedical Co., LTD 58

View Latest Price from 4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Vamifeport pictures 2026-08-30 Vamifeport
2095668-10-1
 $64.00-231.00 99.91% 10g TargetMol Chemicals Inc.
  • Vamifeport pictures
  • Vamifeport
    2095668-10-1
  • $64.00-231.00
  • 99.91%
  • TargetMol Chemicals Inc.

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- Spectrum

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-(2095668-10-1)1HNMR

2095668-10-1 (4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-) Related Search:

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-, hydrochloride (1:1) 4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-, hydrochloride (1:3) 4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- L-Lysinamide, N-(3-methyl-1-oxobutyl)-L-α-aspartyl-L-threonyl-L-histidyl-L-phenylalanyl-L-prolyl-L-cysteinyl-L-isoleucyl-N6-[N-(1-oxohexadecyl)-L-γ-glutamyl]-L-lysyl-L-phenylalanyl-L-α-glutamyl-L-prolyl-L-arginyl-L-seryl-L-lysylglycyl-L-cysteinyl-, cyclic (6→16)-disulfide Thiazolo[5,4-d]pyrimidin-5(4H)-one, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-7-[[(3-fluoro-2-pyridinyl)methyl]amino]-
Fursultiamine

1of2

4-Oxazolecarboxamide, 2-[2-[[2-(1H-benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]- Vamifeport, 10 mM in DMSO 2-(2-((2-(1H-Benzo[d]imidazol-2-yl)ethyl)amino)ethyl)-N-((3-fluoropyridin-2-yl)methyl)oxazole-4-carboxamide VIT-2763 Vamifeport 2-[2-[[2-(1H-Benzimidazol-2-yl)ethyl]amino]ethyl]-N-[(3-fluoro-2-pyridinyl)methyl]-4-oxazolecarboxamide (ACI) 2095668-10-1 C21H21FN6O2